Effects of oxidized and glycated low-density lipoproteins on transcription and secretion of plasminogen activator inhibitor-1 in vascular endothelial cells

Cardiovascular Pathology

Volumn 15, Issue 1, 2006, Pages 3-10

  Ma, Guoping M ^a   Halayko, Andrew J ^a,b   Stelmack, Gerald L ^a,b   Zhu, Fuqin ^a   Zhao, Ruozhi ^a   Hillier, Craig T ^a,b   Shen, Garry X ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MANITOBA INSTITUTE OF CHILD HEALTH   (Canada)

Author keywords

Endothelial cells; Golgi apparatus; Low density lipoprotein; Oxidation and glycation of LDL; Plasminogen activator inhibitor 1 and its promoter

Indexed keywords

BREFELDIN A; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; GLYCATION; GOLGI COMPLEX; HUMAN; HUMAN CELL; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOPROTEINS, LDL; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 30644477115     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2005.08.012     Document Type: Article

References (39)

1. O Saksela, and DB Rifkin Cell-associated plasminogen activation: regulation and physiological functions Annu Rev Cell Biol 4 1988 93 126
2. AR Rezaie Vitronectin functions as a cofactor for rapid inhibition of activated protein C by plasminogen activator inhibitor-1. Implications for the mechanism of profibrinolytic action of activated protein C J Biol Chem 276 2001 15567 15570
3. AM Thogersen, JH Jansson, K Boman, TK Nilsson, L Weinehall, F Huhtasaari, and G Hallmans High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor Circulation 98 1998 2241 2247
4. LJ Garcia Frade, H de la Calle, MC Torrado, JI Lara, L Cuellar, and A Garcia Avello Hypofibrinolysis associated with vasculopathy in noninsulin dependent diabetes mellitus Thromb Res 59 1990 51 59
5. F Carmassi, M Morale, R Puccetti, F De Negri, F Monzani, R Navalesi, and G Mariani Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus Thromb Res 67 1992 643 654
6. V Arnman, A Nilsson, S Stemme, B Risberg, and L Rymo Expression of plasminogen activator inhibitor-1 mRNA in healthy, atherosclerotic and thrombotic human arteries and veins Thromb Res 76 1994 487 499
7. SV Brodsky, K Malinowski, M Golightly, J Jesty, and MS Goligorsky Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential Circulation 106 2002 2372 2378
8. R Egelund, SL Schousboe, L Sottrup-Jensen, KW Rodenburg, and PA Andreasen Type-1 plasminogen-activator inhibitor-conformational differences between latent, active, reactive-centre-cleaved and plasminogen-activator-complexed forms, as probed by proteolytic susceptibility Eur J Biochem 248 1997 775 785
9. L Gombau, and RR Schleef Processing of type 1 plasminogen activator inhibitor (PAI-1) into the regulated secretory pathway J Biol Chem 269 1994 3875 3880
10. JL Chuang, and RR Schleef Recombinant Semliki Forest virus enhanced plasminogen activator inhibitor 1 expression and storage in the megakaryocytic cell line MEG-01 J Cell Biochem 82 2001 277 289
11. TJ Podor, and DJ Loskutoff Immunoelectron microscopic localization of type 1 plasminogen activator inhibitor in the extracellular matrix of transforming growth factor-beta-activated endothelial cells Ann N Y Acad Sci 667 1992 46 49
12. J Grulich-Henn, and G Muller-Berghaus Regulation of endothelial tissue plasminogen activator and plasminogen activator inhibitor type 1 synthesis by diacylglycerol, phorbol ester, and thrombin Blut 61 1990 38 44
13. JJ Emeis, and T Kooistra Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells J Exp Med 163 1986 1260 1266
14. A Stiko-Rahm, B Wiman, A Hamsten, and J Nilsson Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein Arteriosclerosis 10 1990 1067 1073
15. E Tremoli, M Camera, P Maderna, L Sironi, L Prati, S Colli, F Piovella, F Bernini, A Corsini, and L Mussoni Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs. An LDL receptor-independent phenomenon Arterioscler Thromb 13 1993 338 346
16. S Ren, RY Man, A Angel, and GX Shen Oxidative modification enhances lipoprotein(a)-induced overproduction of plasminogen activator inhibitor-1 in cultured vascular endothelial cells Atherosclerosis 128 1997 1 10
17. D Steinberg, S Parthasarathy, TE Carew, JC Khoo, and JL Witztum Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity N Engl J Med 320 1989 915 924
18. TJ Lyons, JW Baynes, JS Patrick, JA Colwell, and MF Lopes-Virella Glycosylation of low density lipoprotein in patients with type 1 (insulin-dependent) diabetes: correlations with other parameters of glycaemic control Diabetologia 29 1986 685 689
19. K Kobayashi, J Watanabe, F Umeda, and H Nawata Glycation accelerates the oxidation of low density lipoprotein by copper ions J Endocr 42 1995 461 465
20. J Zhang, S Ren, D Sun, and GX Shen Influence of glycation on LDL-induced generation of fibrinolytic regulators in vascular endothelial cells Arterioscler Thromb Vasc Biol 18 1998 1140 1148
21. S Ren, S Shatadal, and GX Shen Protein kinase C-beta mediates lipoprotein-induced generation of PAI-1 from vascular endothelial cells Am J Physiol Endocrinol Metab 278 2000 E656 E662
22. S Ren, H Lee, L Hu, L Lu, and GX Shen Impact of diabetes-associated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells J Clin Endocrinol Metab 87 2002 286 291
23. BA Allison, L Nilsson, F Karpe, A Hamsten, and P Eriksson Effects of native, triglyceride-enriched, and oxidatively modified LDL on plasminogen activator inhibitor-1 expression in human endothelial cells Arterioscler Thromb Vasc Biol 19 1999 1354 1360
24. H Ohkawa, N Ohishi, and K Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal Biochem 95 1979 351 358
25. PB Duell, JF Oram, and EL Bierman Nonenzymatic glycosylation of HDL resulting in inhibition of high-affinity binding to cultured human fibroblasts Diabetes 39 1990 1257 1263
26. BE Nickel, E Kardami, and PA Cattini Differential expression of human placental growth-hormone variant and chorionic somatomammotropin in culture J Biochem 267 1990 653 658
27. AJ Halayko, B Camoretti-Mercado, SM Forsythe, JE Vieira, RW Mitchell, ME Wylam, MB Hershenson, and J Solway Divergent differentiation paths in airway smooth muscle culture: induction of functionally contractile myocytes Am J Physiol Lung Cell Mol Physiol 276 2000 L197 L206
28. AD Linstedt, and HP Hauri Giantin, a novel conserved Golgi membrane protein containing a cytoplasmic domain of at least 350 kDa Mol Biol Cell 4 1993 679 693
29. RD Klausner, JG Donaldson, J Lippincott-Schwartz, and A Brefeldin Insights into the control of membrane traffic and organelle structure J Cell Biol 116 1992 1071 1080
30. PM Ridker Intrinsic fibrinolytic capacity and systemic inflammation: novel risk factors for arterial thrombotic disease Haemostasis 27 Suppl 1 1997 2 11
31. E Maggi, G Finardi, M Poli, P Bollati, M Filipponi, PL Stefano, G Paolini, A Grossi, P Clot, and E Albano Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk Coron Artery Dis 4 1993 1119 1122
32. H Itabe, E Takeshima, H Iwasaki, J Kimura, Y Yoshida, T Imanaka, and T Takano A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides J Biol Chem 269 1994 15274 15279
33. JA Berliner, MC Territo, A Sevanian, S Ramin, JA Kim, B Bamshad, M Esterson, and AM Fogelman Minimally modified low density lipoprotein stimulates monocyte endothelial interactions J Clin Invest 85 1990 1260 1266
34. DW Morel, PE DiCorleto, and GM Chisolm Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation Arteriosclerosis 4 1984 357 364
35. S Ren, and GX Shen Impact of antioxidants and HDL on glycated LDL-induced generation of fibrinolytic regulators from vascular endothelial cells Arterioscler Thromb Vasc Biol 20 2000 1688 1693
36. F Lupu, GE Bergonzelli, DA Heim, E Cousin, CY Genton, F Bachmann, and EK Kruithof Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries Arterioscler Thromb 13 1993 1090 1100
37. E Bianchi, RL Cohen, A Dai, AT Thor, MA Shuman, and HS Smith Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer Int J Cancer 60 1995 597 603
38. DM Underhill, DA Owensby, PA Morton, and AL Schwartz Endocytosis and lysosomal delivery of tissue plasminogen activator-inhibitor 1 complexes in Hep G2 cells Blood 80 1992 2746 2754
39. C Rosnoblet, UM Vischer, RD Gerard, JC Irminger, PA Halban, and EK Kruithof Storage of tissue-type plasminogen activator in Weibel-Palade bodies of human endothelial cells Arterioscler Thromb Vasc Biol 19 1999 1796 1803